Literature DB >> 10438835

CD4-Chemokine receptor hybrids in human immunodeficiency virus type 1 infection.

P J Klasse1, M M Rosenkilde, N Signoret, A Pelchen-Matthews, T W Schwartz, M Marsh.   

Abstract

Most human immunodeficiency virus (HIV) strains require both CD4 and a chemokine receptor for entry into a host cell. In order to analyze how the HIV-1 envelope glycoprotein interacts with these cellular molecules, we constructed single-molecule hybrids of CD4 and chemokine receptors and expressed these constructs in the mink cell line Mv-1-lu. The two N-terminal (2D) or all four (4D) extracellular domains of CD4 were linked to the N terminus of the chemokine receptor CXCR4. The CD4(2D)CXCR4 hybrid mediated infection by HIV-1(LAI) to nearly the same extent as the wild-type molecules, whereas CD4(4D)CXCR4 was less efficient. Recombinant SU(LAI) protein competed more efficiently with the CXCR4-specific monoclonal antibody 12G5 for binding to CD4(2D)CXCR4 than for binding to CD4(4D)CXCR4. Stromal cell-derived factor 1 (SDF-1) blocked HIV-1(LAI) infection of cells expressing CD4(2D)CXCR4 less efficiently than for cells expressing wild-type CXCR4 and CD4, whereas down-modulation of CXCR4 by SDF-1 was similar for hybrids and wild-type CXCR4. In contrast, the bicyclam AMD3100, a nonpeptide CXCR4 ligand that did not down-modulate the hybrids, blocked hybrid-mediated infection at least as potently as for wild-type CXCR4. Thus SDF-1, but not the smaller molecule AMD3100, may interfere at multiple points with the binding of the surface unit (SU)-CD4 complex to CXCR4, a mechanism that the covalent linkage of CD4 to CXCR4 impedes. Although the CD4-CXCR4 hybrids yielded enhanced SU interactions with the chemokine receptor moiety, this did not overcome the specific coreceptor requirement of different HIV-1 strains: the X4 virus HIV-1(LAI) and the X4R5 virus HIV-1(89. 6), unlike the R5 strain HIV-1(SF162), infected Mv-1-lu cells expressing the CD4(2D)CXCR4 hybrid, but none could use hybrids of CD4 and the chemokine receptor CCR2b, CCR5, or CXCR2. Thus single-molecule hybrid constructs that mimic receptor-coreceptor complexes can be used to dissect coreceptor function and its inhibition.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10438835      PMCID: PMC104272          DOI: 10.1128/JVI.73.9.7453-7466.1999

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

1.  Promiscuous use of CC and CXC chemokine receptors in cell-to-cell fusion mediated by a human immunodeficiency virus type 2 envelope protein.

Authors:  R Bron; P J Klasse; D Wilkinson; P R Clapham; A Pelchen-Matthews; C Power; T N Wells; J Kim; S C Peiper; J A Hoxie; M Marsh
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

Review 2.  Improving structural integrity of cryosections for immunogold labeling.

Authors:  W Liou; H J Geuze; J W Slot
Journal:  Histochem Cell Biol       Date:  1996-07       Impact factor: 4.304

3.  A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding.

Authors:  C D Rizzuto; R Wyatt; N Hernández-Ramos; Y Sun; P D Kwong; W A Hendrickson; J Sodroski
Journal:  Science       Date:  1998-06-19       Impact factor: 47.728

4.  AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor.

Authors:  G A Donzella; D Schols; S W Lin; J A Esté; K A Nagashima; P J Maddon; G P Allaway; T P Sakmar; G Henson; E De Clercq; J P Moore
Journal:  Nat Med       Date:  1998-01       Impact factor: 53.440

5.  A new classification for HIV-1.

Authors:  E A Berger; R W Doms; E M Fenyö; B T Korber; D R Littman; J P Moore; Q J Sattentau; H Schuitemaker; J Sodroski; R A Weiss
Journal:  Nature       Date:  1998-01-15       Impact factor: 49.962

6.  Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains.

Authors:  A L Edinger; A Amedee; K Miller; B J Doranz; M Endres; M Sharron; M Samson; Z H Lu; J E Clements; M Murphey-Corb; S C Peiper; M Parmentier; C C Broder; R W Doms
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

7.  Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor fusin/CXCR-4.

Authors:  D Schols; J A Esté; G Henson; E De Clercq
Journal:  Antiviral Res       Date:  1997-08       Impact factor: 5.970

8.  Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1.

Authors:  E J Platt; K Wehrly; S E Kuhmann; B Chesebro; D Kabat
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

9.  Role of CD4 endocytosis in human immunodeficiency virus infection.

Authors:  A Pelchen-Matthews; P Clapham; M Marsh
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

10.  Mutations along transmembrane segment II of the NK-1 receptor affect substance P competition with non-peptide antagonists but not substance P binding.

Authors:  M M Rosenkilde; M Cahir; U Gether; S A Hjorth; T W Schwartz
Journal:  J Biol Chem       Date:  1994-11-11       Impact factor: 5.157

View more
  9 in total

1.  Env-glycoprotein heterogeneity as a source of apparent synergy and enhanced cooperativity in inhibition of HIV-1 infection by neutralizing antibodies and entry inhibitors.

Authors:  Thomas J Ketas; Sophie Holuigue; Katie Matthews; John P Moore; Per Johan Klasse
Journal:  Virology       Date:  2011-10-22       Impact factor: 3.616

2.  The human cytomegalovirus US28 protein is located in endocytic vesicles and undergoes constitutive endocytosis and recycling.

Authors:  A Fraile-Ramos; T N Kledal; A Pelchen-Matthews; K Bowers; T W Schwartz; M Marsh
Journal:  Mol Biol Cell       Date:  2001-06       Impact factor: 4.138

3.  Retroviral vector targeting to human immunodeficiency virus type 1-infected cells by receptor pseudotyping.

Authors:  N V Somia; H Miyoshi; M J Schmitt; I M Verma
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

4.  Modeling how many envelope glycoprotein trimers per virion participate in human immunodeficiency virus infectivity and its neutralization by antibody.

Authors:  Per Johan Klasse
Journal:  Virology       Date:  2007-09-07       Impact factor: 3.616

5.  Thermal stability of the human immunodeficiency virus type 1 (HIV-1) receptors, CD4 and CXCR4, reconstituted in proteoliposomes.

Authors:  Mikhail A Zhukovsky; Stéphane Basmaciogullari; Beatriz Pacheco; Liping Wang; Navid Madani; Hillel Haim; Joseph Sodroski
Journal:  PLoS One       Date:  2010-10-13       Impact factor: 3.240

6.  Structural Diversity in Conserved Regions Like the DRY-Motif among Viral 7TM Receptors-A Consequence of Evolutionary Pressure?

Authors:  Ann-Sofie Mølleskov Jensen; Alexander Hovard Sparre-Ulrich; Nicholas Davis-Poynter; Mette Marie Rosenkilde
Journal:  Adv Virol       Date:  2012-07-30

7.  Endocytosis and recycling of the HIV coreceptor CCR5.

Authors:  N Signoret; A Pelchen-Matthews; M Mack; A E Proudfoot; M Marsh
Journal:  J Cell Biol       Date:  2000-12-11       Impact factor: 10.539

8.  RT-SHIV, an infectious CCR5-tropic chimeric virus suitable for evaluating HIV reverse transcriptase inhibitors in macaque models.

Authors:  Yonghou Jiang; Baoping Tian; Mohammed Saifuddin; Michael B Agy; Peter Emau; J Scott Cairns; Che-Chung Tsai
Journal:  AIDS Res Ther       Date:  2009-11-05       Impact factor: 2.250

9.  Single-Molecule Super-Resolution Imaging of T-Cell Plasma Membrane CD4 Redistribution upon HIV-1 Binding.

Authors:  Yue Yuan; Caron A Jacobs; Isabel Llorente Garcia; Pedro M Pereira; Scott P Lawrence; Romain F Laine; Mark Marsh; Ricardo Henriques
Journal:  Viruses       Date:  2021-01-19       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.